MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with M

Mebeverine

Mebeverine 135mg tablets

Use with caution

Stability notes for Mebeverine 135mg tablets

Protect from moisture.
Protect from light.     Protect from heat.
Manufacturer recommends storing in original container    Stability data for 5 weeks in a sealed MCA.

Provenance

This recommendation is based on the products Colofac 135mg tablets (Viatris Healthcare Limited) and Mebeverine 135mg tablets (Aurobindo Pharma-Milpharm Ltd).

Suppliers (21) of Mebeverine 135mg tablets
Colofac 135mg tablets (Ceuta Healthcare Ltd)
Colofac 135mg tablets (CST Pharma Ltd)
Colofac 135mg tablets (Lexon (UK) Ltd)
Colofac 135mg tablets (Sigma Pharmaceuticals Plc)
Colofac IBS 135mg tablets (Ceuta Healthcare Ltd)
Mebeverine 135mg tablets (A A H Pharmaceuticals Ltd)
Mebeverine 135mg tablets (Alissa Healthcare Research Ltd)
Mebeverine 135mg tablets (Alliance Healthcare (Distribution) Ltd)
Mebeverine 135mg tablets (Almus Pharmaceuticals Ltd)
Mebeverine 135mg tablets (Aspire Pharma Ltd)
Mebeverine 135mg tablets (Bristol Laboratories Ltd)
Mebeverine 135mg tablets (Key Pharmaceuticals Ltd)
Mebeverine 135mg tablets (Medihealth (Northern) Ltd)
Mebeverine 135mg tablets (Medreich Plc)
Mebeverine 135mg tablets (Milpharm Ltd)
Mebeverine 135mg tablets (Noumed Life Sciences Ltd)
Mebeverine 135mg tablets (Phoenix Healthcare Distribution Ltd)
Mebeverine 135mg tablets (Sigma Pharmaceuticals Plc)
Mebeverine 135mg tablets (Teva UK Ltd)
Mebeverine 135mg tablets (Zentiva Pharma UK Ltd)
Numark Mebeverine 135mg tablets (Numark Ltd)

Mebeverine 200mg modified-release capsules

Use with caution

Stability notes for Mebeverine 200mg modified-release capsules

Protect from moisture. Manufacturer recommends storing in original container.    No stability data available.

Provenance

This recommendation is based on the products Colofac 200mg MR capsules (Cooper Consumer Health B.V) and Mebeverine 200mg modified release capsules (Aspire Pharma Ltd).

Suppliers (5) of Mebeverine 200mg modified-release capsules
Aurobeverine MR 200mg capsules (Milpharm Ltd)
Colofac MR 200mg capsules (Ceuta Healthcare Ltd)
Colofac MR 200mg capsules (Lexon (UK) Ltd)
Colofac MR 200mg capsules (Sigma Pharmaceuticals Plc)
Mebeverine 200mg modified-release capsules (Aspire Pharma Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.